Literature DB >> 7430116

Cobalamin-dependent formation of leucine and beta-leucine by rat and human tissue. Changes in pernicious anemia.

J M Poston.   

Abstract

Circulating levels of beta-leucine are elevated in the cobalamin-deficient state of pernicious anemia. Levels of leucine, on the other hand, are much lower. It is proposed that leucine 2,3-aminomutase, the cobalamin-dependent enzyme that catalyzes the interconversion of leucine and beta-leucine, is the affected enzyme in pernicious anemia and causes these results by preventing the synthesis of leucine from beta-leucine. The synthesis of leucine by human leukocytes and hair roots and by rat liver extracts has been shown to occur when either branched chain fatty acids or valine metabolites are the substances. The synthesis is dependent upon adenosylcobalamin and is inhibited by intrinsic factor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430116

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  Cobalamin deficiency and related disorders in infancy and childhood.

Authors:  D M Matthews; J C Linnell
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

2.  Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats.

Authors:  H Kondo; M L Osborne; J F Kolhouse; M J Binder; E R Podell; C S Utley; R S Abrams; R H Allen
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

Review 3.  Health hazards and nitrous oxide: a time for reappraisal.

Authors:  J A Yagiela
Journal:  Anesth Prog       Date:  1991 Jan-Feb

4.  [Vitamin B12 as a biologically active model compound].

Authors:  B Zagalak
Journal:  Naturwissenschaften       Date:  1982-02

Review 5.  Genetic patterns of transcobalamin II and the relationships with congenital defects.

Authors:  M Fràter-Schröder
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.